Leritrelvir
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Leritrelvir (RAY1216) is an antiviral drug which acts as a 3C-like protease inhibitor. It was developed and approved in China for treatment of COVID-19.
Leritrelvir (RAY1216) is an antiviral drug which acts as a 3C-like protease inhibitor. It was developed and approved in China for treatment of COVID-19.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1371307255 under CC BY-SA 4.0; modifications have been made.